基于网络药理学和分子对接技术探究黄连降糖方降低血糖的潜在机制
To Investigate the Potential Mechanism of Huanglian Jiangtang Formula Lowering Blood Sugar in View of Network Pharmacology and Molecular Docking Technology.
作者信息
Li Fang Xu, Zhou Ziting, Lu Cheng, Pang Guoming, Lu Zhigang
机构信息
Hospital of Traditional Chinese Medicine, Kaifeng 475000, Henan, China.
Nanjing University of Traditional Chinese Medicine, Nanjing 210023, Jiangsu, China.
出版信息
Evid Based Complement Alternat Med. 2023 Feb 16;2023:2827938. doi: 10.1155/2023/2827938. eCollection 2023.
OBJECTIVE
In view of network pharmacology and molecular docking technology, to explore the targets as well as effect mechanism of the Huanglian Jiangtang formula (including , , rhubarb wine, , , and ) in the type II diabetes therapy.
METHODS
TCMSP and Batman database (DB) were used to retrieve the chemical components and action targets of drugs; GeneCards, OMIM, TTD, DrugBank, and other databases were applied to screen the disease targets. We used the UniProt DB to annotate the targets before building the drug-compound-target network with Cytoscape 3.9.1. We also exploited the String DB to construct the protein-protein interaction (PPI) network. In addition, the targets for the treatment of type II diabetes were searched in the DrugBank, OMIM, GeneCards, and TTD database; then, we utilized Venn to intersect the key targets for the therapy of type II diabetes and active ingredient targets to obtain common targets. Furthermore, we exploited the common targets using GO and KEGG enrichment analysis method. The common targets and core components were analyzed by molecular docking using the AutoDock software.
RESULTS
A total of 61 effective components of this compound were screened out; drugs and type II diabetes have 278 common targets; the PPI network screened core target proteins such as CDKN1A, CDK2, and E2F1 with the help of molecular docking technology; the three main compounds including quercetin, kaempferol, and gamma-aminobutyric acid were obtained. Besides, the key target proteins had excellent binding properties with the main components. The signal pathways of six compound interventions in type II diabetes were mostly related to cancer, cocaine addiction, aminoacyl-tRNA biosynthesis, glycine, serine, threonine metabolism, platinum drug resistance, and other pathways, according to the KEGG enrichment analysis method.
CONCLUSION
In the treatment of diabetes, the Huanglian Jiangtang formula has sorts of properties especially in the aspects of composition, target, and pathway. Its molecular target and mechanism of action may be related to pathways in cancer, cocaine addiction, aminoacyl-tRNA biosynthesis, glycine, serine, threonine metabolism, platinum drug resistance, and other pathways. This conclusion can provide theoretical support and science for further research.
目的
基于网络药理学和分子对接技术,探讨黄连降糖方(包括黄连、生姜、大黄酒、生地黄、麦冬、天花粉)治疗2型糖尿病的靶点及作用机制。
方法
利用中药系统药理学数据库与分析平台(TCMSP)和中药分子机制生物信息学数据库(Batman数据库)检索药物的化学成分及作用靶点;应用基因卡片数据库(GeneCards)、在线人类孟德尔遗传数据库(OMIM)、治疗靶点数据库(TTD)、药物银行数据库(DrugBank)等筛选疾病靶点。利用通用蛋白质数据库(UniProt数据库)对靶点进行注释,然后用Cytoscape 3.9.1构建药物-化合物-靶点网络。利用搜索工具检索相互作用基因数据库(String数据库)构建蛋白质-蛋白质相互作用(PPI)网络。此外,在DrugBank、OMIM、GeneCards和TTD数据库中检索治疗2型糖尿病的靶点;然后,利用维恩图将2型糖尿病治疗的关键靶点与活性成分靶点进行交叉,得到共同靶点。此外,采用基因本体论(GO)和京都基因与基因组百科全书(KEGG)富集分析方法对共同靶点进行分析。利用自动对接软件(AutoDock软件)通过分子对接对共同靶点和核心成分进行分析。
结果
共筛选出该复方61个有效成分;药物与2型糖尿病有278个共同靶点;PPI网络借助分子对接技术筛选出细胞周期蛋白依赖性激酶抑制因子1A(CDKN1A)、细胞周期蛋白依赖性激酶2(CDK2)和E2F转录因子1(E2F1)等核心靶蛋白;得到槲皮素、山奈酚和γ-氨基丁酸3种主要化合物。此外,关键靶蛋白与主要成分具有良好的结合特性。根据KEGG富集分析方法,6种化合物干预2型糖尿病的信号通路大多与癌症、可卡因成瘾、氨酰基-tRNA生物合成、甘氨酸、丝氨酸、苏氨酸代谢、铂类耐药等通路有关。
结论
黄连降糖方在治疗糖尿病方面在成分、靶点和通路等方面具有多种特性。其分子靶点及作用机制可能与癌症、可卡因成瘾、氨酰基-tRNA生物合成、甘氨酸、丝氨酸、苏氨酸代谢、铂类耐药等通路有关。该结论可为进一步研究提供理论支持和科学依据。